Sexually Transmitted Diseases
Improving provider adherence to treatment recommendations for antibiotic use across the full spectrum of healthcare settings is an integral part of a comprehensive approach to combating the emergence of antimicrobial-resistant gonorrhea.
The authors concluded, "There is high-certainty evidence that HPV vaccines protect against cervical precancer in adolescent girls and young women aged 15 to 26," while also indicated that future studies should have long-term follow-up.
Further investigation into new strategies to prevent herpes simplex virus (HSV) acquisition in pregnant women and to prevent HSV transmission from mother to neonate are warranted.
Based on these data and the potential change in follow-up care, the HPV mRNA assay should not be used for a primary screening tool for cervical cancer.
The HR-HPV types covered by the nonavalent HPV vaccine had similar clearance rates to HR-HPV types not included, and women infected with multiple anogenital HR-HPV types had lower rates of clearance than women infected with only 1 type.
In the future, doxycycline post-exposure prophylaxis might become an effective addition to a combined intervention approach to reduce the high rate of STIs in PrEP users.
Adolescent consent may help minimize delays in vaccination and reduce the overall incidence of cervical, oropharyngeal, and anal cancers.
There were positive associations for TV infection prevalence with female sex, black race, older age, being below the poverty level, and having 2 or more sexual partners.
A bundled intervention including communication skills training and performance feedback may improve human papillomavirus vaccination.
For adolescents, a health care professional HPV vaccine communication intervention is associated with improved HPV vaccine series initiation and completion.
Study confirms HPV16 as an important determinant of high-grade lesions and supports its place as a priority for anal cancer prevention.
Behavioral interventions that include sexual risk reduction combined with alcohol- and cannabis-focused elements are effective in reducing STI incidence among adolescents.
The increasing prevalence of macrolide resistance underscores the need for research focused on identifying a safe and effective treatment for Mycoplasma genitalium.
CDC publishes the latest estimates of HSV-1, HSV-2 prevalence in the United States.
Young, asymptomatic, high-risk women in the United States have high rates of prevalent, incident, and persistent M genitalium infections, supporting the need for clinical trials to assess the effect of M genitalium screening programs on female reproductive health outcomes.
A chlamydia infection that has been identified during pregnancy and treated does not appear to result in a substantial increase in the risk of preterm birth compared with the risk in women tested and shown to not have a chlamydia infection.
The USPSTF says there is considerable net benefit to screening for syphilis infection in pregnant women.
Study provides the first report of the detection rate for a T vaginalis nucleotide polymorphism associated with metronidazole resistance
Learn about drugs in the pipeline for treatment-resistant gonorrhea.
Although a positive impact on behavior change has been reported following the implementation of curriculum-based programs, there is a lack of clear evidence that school-based educational interventions directly prevent HIV/STIs.
The limitations of herd protection for vaccine-type HPV was examined in a recent study.
Study was the first to examine the geographical variation of seminal HPV prevalence, showing a relatively high prevalence in fertility clinic attendees when compared to the general population.
For patients with HPV-associated cancers, there are large disparities in survival based on sex, race, and age.
Successive negative HPV and cytology co-testing is linked decrease risks of cervical cancer.
Findings inform further refinement of cervical cancer screening algorithms for vaccinated populations.
Incidence of juvenile-onset respiratory papillomatosis declined with the introduction of a HPV vaccination program.
Many US physicians recommended primary HPV testing for women of all ages, contrary to guidelines which limit this screening approach to women ≥25 years old.
The incidence of HPV-related oropharyngeal squamous cell carcinoma has increased in men dramatically and that increase is projected to continue until 2060.
Secnidazole is a 5-nitroimidazole with demonstrated in vitro antimicrobial activity against many anaerobic Gram-negative and Gram-positive bacterial species, while sparing Lactobacillus species.
Vaginal microbiota dominated by L iners has been shown to exhibit rapid change in composition in and out of community states similar to bacterial vaginosis.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Importance of PrEP for People Involved in Criminal Justice Systems
- Increasing Incidence of Syphilis in People With HIV
- FDA: Possible Risk of Neural Tube Birth Defects With Certain Antiretroviral Agents
- Fungal Infections of the CNS: Diagnostic and Treatment Approaches
- Study Supports Development of a Vaccine for Recurrent Vulvovaginal Candidiasis
- Early Flow Cytometry Predictive of Clinical Deterioration in Sepsis
- Could a New Universal Tuberculosis Regimen Help End the TB Pandemic?
- Hepatitis C Virus Infection Linked to Gut Dysbiosis
- Two Hepatitis C Virus Infection Treatments to Be Discontinued
- Antibiotic Use During Pregnancy May Increase Risk for Childhood Asthma